Document Detail


Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension.
MedLine Citation:
PMID:  11470697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To compare the effect on intraocular pressure (IOP) over 24 hours after 4 weeks of treatment with latanoprost 0.005% and timolol gel 0.5%. DESIGN: Randomized, open, crossover single-center study. PARTICIPANTS: Twenty-seven patients with ocular hypertension. METHODS: The patients were randomly assigned to 4 weeks of latanoprost 0.005% once daily or timolol gel 0.5% once daily, with a 4-week washout period before switching therapy. MAIN OUTCOME MEASURES: Measurement of IOP during 24 hours of hospitalization. Blood pressure and heart rate were also measured repeatedly over the 24 hours. Daytime mean IOP, nighttime mean IOP, and 24-hour mean IOP were calculated as IOP area under the curve (AUC) divided by time in hours. RESULTS: The mean IOP during daytime (7 AM to 10 PM) was 13.5 +/- 0.4 mmHg (daytime IOP, AUC/15 hours, least square mean +/- standard error of the mean [SEM]) in the latanoprost group, and 14.8 +/- 0.4 mmHg in the timolol gel group. This difference of 1.3 +/- 0.3 mmHg was statistically significant in favor of latanoprost (P < 0.001; 95% confidence interval [CI], 0.7, 2.0). The mean IOP at night (10 PM to 7 AM) was 13.7 +/- 0.4 mmHg for latanoprost (nighttime IOP, AUC/9 hours, least square mean +/- SEM) and 15.9 +/- 0.5 mmHg for timolol gel, with a difference of 2.2 +/- 0.3 mmHg (P < 0.001; 95% CI, 1.5, 2.8). At every measured time point during the 24 hours, latanoprost reduced IOP more than timolol. There was no difference between the two treatment groups regarding blood pressure and heart rate. CONCLUSIONS: Latanoprost reduced mean 24-hour IOP, mean daytime IOP, and mean nighttime IOP statistically significantly more than timolol. Also, latanoprost reduced IOP more effectively at every measured time point over the 24 hours compared with timolol gel.
Authors:
L I Larsson
Related Documents :
11765147 - Preclinical efficacy of travoprost, a potent and selective fp prostaglandin receptor ag...
17601447 - Corneal thickness and relating factors in a population-based study in japan: the tajimi...
20056337 - Alzheimer's disease: cerebral glaucoma?
19049297 - Intraocular pressure lowering, change of antiapoptotic molecule expression, and neurore...
7728787 - Cilazapril with adjunctive hydrochlorothiazide. analysis of safety and efficacy in hype...
3182527 - Effect of hypoxia on bronchial circulation.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Ophthalmology     Volume:  108     ISSN:  0161-6420     ISO Abbreviation:  Ophthalmology     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-07-25     Completed Date:  2001-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7802443     Medline TA:  Ophthalmology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1439-44     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, Uppsala University Hospital, Uppsala, Sweden. Lill-Inger.Larsson@ogon.uu.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antihypertensive Agents / administration & dosage*
Blood Pressure
Circadian Rhythm*
Cross-Over Studies
Female
Gels
Heart Rate
Humans
Intraocular Pressure / drug effects*
Male
Middle Aged
Ocular Hypertension / drug therapy*
Ophthalmic Solutions
Prostaglandins F, Synthetic / administration & dosage*
Timolol / administration & dosage*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Gels; 0/Ophthalmic Solutions; 0/Prostaglandins F, Synthetic; 130209-82-4/latanoprost; 26839-75-8/Timolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rate...
Next Document:  Color Doppler imaging study of retrobulbar hemodynamics in chronic angle-closure glaucoma.